- Market Capitalization, $K 651,019
- Shares Outstanding, K 214,151
- Annual Sales, $ 0 K
- Annual Income, $ -117,800 K
- 60-Month Beta 2.48
- Price/Sales N/A
- Price/Cash Flow N/A
- Price/Book 4.45
|Period||Period Low||Period High||Performance|
| || |
-0.23 (-7.21%)since 07/13/20
| || |
+0.19 (+6.51%)since 05/13/20
| || |
-2.15 (-41.60%)since 08/13/19
Ziopharm Oncolog (NASDAQ:ZIOP) traded in a range yesterday that spanned from a low of $3.02 to a high of $3.46. Yesterday, the shares fell 10.5%, which took the trading range below the 3-day low of $3.07...
BOSTON (AP) _ Ziopharm Oncology Inc. (ZIOP) on Thursday reported a loss of $18.6 million in its second quarter.
- Enrollment completed in Controlled IL-12 phase 2 clinical trial with Regeneron's Libtayo -
Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced the Company will host a conference call and webcast on Thursday, August 6, at 4:30 pm EDT to provide a corporate update and discuss financial results...
- Industry veteran entrepreneur with 20+ years' experience founding and financing successful, innovative biotech companies including GenScript and Legend Biotech -
Ziopharm Oncology, Inc. ("Ziopharm" or "the Company") (Nasdaq:ZIOP) today announced that 36 subjects have been enrolled in the phase 2 clinical trial evaluating Ad-RTS-hIL-12 with veledimex (Controlled...
Investors need to pay close attention to Ziopharm Oncology (ZIOP) stock based on the movements in the options market lately.
Ziopharm Oncology, Inc. ("Ziopharm" or "the Company") (Nasdaq: ZIOP), today announced the appointment of renowned oncology and immunotherapy pioneer, Carl June, M.D., as Chairman of its newly formed Scientific...
Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer of Ziopharm, is scheduled to participate in a webcast panel session titled Cell Therapy:...
Ziopharm Oncolog (NASDAQ:ZIOP) traded in a range yesterday that spanned from a low of $2.89 to a high of $3.02. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $2.90...
|Ziopharm Oncology IN|
|Bioshares Biotech Clinical Trial|
|Ishares Genomics Immunology and Healthcare ETF|
|Micro-Cap Ishares ETF|
|S&P Biotech SPDR|
|Principal Healthcare Innovators Index|